IdentifySensors provides a platform for developing and deploying nanosensor applications within the Internet of Things (IoT) ecosystem. Their platform enables integration of nanosensor data with existing IoT infrastructure for various monitoring and detection applications.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods for detecting pathogens often rely on complex chemical tests that require enzymatic amplification, reagents, and skilled personnel, leading to slower turnaround times and higher costs. Existing over-the-counter self-tests may lack the sensitivity to detect early or asymptomatic infections, hindering timely intervention and disease management.
Solution
IdentifySensors Biologics is developing the Check4 platform, a digital diagnostic solution that uses graphene-based electronic biosensors to rapidly detect and differentiate multiple pathogens at the molecular level from saliva samples. The Check4 platform eliminates the need for enzymatic amplification and reagents, offering a faster and more cost-effective alternative to traditional PCR testing. The system comprises a reusable Bluetooth reader and disposable test cartridges containing graphene sensors functionalized to detect specific DNA or RNA sequences. Results are sent to a smartphone app or clinical database, enabling remote monitoring and timely treatment decisions.
Target Audience
The primary target audience includes consumers seeking rapid and accurate over-the-counter self-tests, as well as medical professionals and healthcare providers needing point-of-care diagnostic solutions for infectious diseases.
Features
- Graphene-based electronic biosensors for direct detection of pathogens in saliva
- Rapid multiplex detection of up to three pathogens simultaneously
- No enzymatic amplification or reagents required
- Bluetooth reader for data transmission to a smartphone app or clinical database
- Disposable test cartridges with sensors targeting conserved regions of the genome
- High sensitivity, with the potential to detect infections before symptoms appear
- Potential for over-the-counter and point-of-care use
- Cloud connectivity for remote monitoring and data analysis
- Expanding test menu to include respiratory, gastrointestinal, and sexually transmitted pathogens